Risk factors for the development of extended-spectrum beta-lactamase- producing bacteria in nonhospitalized patients

Keyphrases

• Antibiotic Treatment 33%
• Catheter-associated Urinary Tract Infection (CAUTI) 33%
• Cephalosporins 33%
• Clinical Data 33%
• Community Setting 33%
• Diabetes 33%
• Extended-spectrum beta-lactamase-producing Escherichia Coli 100%
• Extended-spectrum β-lactamase 66%
• Hospitalized Patients 33%
• Independent Risk Factors 33%
• Klebsiella Pneumoniae (K. pneumoniae) 33%
• Male Gender 33%
• Multivariate Analysis 33%
• Negative Strain 33%
• Non-hospitalized 100%
• Penicillin 33%
• Previous Hospitalization 33%
• Quinolones 33%
• Risk Factors 100%
• Third-generation Cephalosporins 33%

Immunology and Microbiology

• Klebsiella pneumoniae 100%
• Penicillin 100%
• Urinary Tract 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Second Generation Cephalosporin 25%
• Third Generation Cephalosporin 25%